A new extract of the plant calendula officinalis produces a dual in vitro effect: Cytotoxic anti-tumor activity and lymphocyte activation

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Jiménez Medina, Eva ^a   Garcia Lora, Angel ^a   Paco, Laura ^a   Algarra, Ignacio ^b   Collado, Antonia ^a   Garrido, Federico ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b UNIVERSITY OF JAÉN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BROXURIDINE; CALENDULA EXTRACT; CALENDULA OFFICINALIS EXTRACT; PACLITAXEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL COUNT; CELL CYCLE ARREST; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; FIBROSARCOMA; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; LEUKEMIA; LUNG CANCER; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MARIGOLD; MELANOMA; MOUSE; NONHUMAN; PANCREAS CANCER; PROSTATE CANCER; RAT; UTERINE CERVIX CANCER;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CALENDULA; CELL LINE, TUMOR; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 33746336530     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-119     Document Type: Article

References (32)

1. Park EJ, Pezzuto JM: Botanicals in cancer chemoprevention. Cancer Metastasis Rey 2002, 21:231-255.
2. Huang KC: The Pharmacology of Chinese Herbs. 2nd edition. CRC Press, Boca Raton; 1999:457-483.
3. Demeule M, Michaud-Levesque J, Annabi B, Gingras D, Bolvin D, Jodoin J, Lamy S, Bertrand Y, Beliveau R: Green tea catechins as novel antitumor and antiangiogenic compounds. Curr Med Chem Anti-Cancer Agents 2002, 2:441-463.
4. Dorai T, Aggarwal BB: Role of chemopreventive agents in cancer therapy. Cancer Lett 2004, 215:129-140.
5. Ghersi D, Wilcken N, Simes RJ: A systematic review of taxane-containing regimens for metastatic breast cancer. Br J Cancer 2005, 93:293-301.
6. Lopez-Lazaro M: Flavonoids as anticancer agents: structure-activity relationship study. Curr Med Chem Anti-Cancer Agents 2002, 2:691-714.
7. Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003, 3:768-780.
8. Philip PA: Experience with docetaxel in the treatment of gastric cancer. Semin Oncol 2005, 32:S24-38.
9. Chung KT, Wong TY, Wei CI, Huang YW, Lin Y: Tannins and human health: a review. Crit Rev Food Sci Nutr 1998, 38:421-464.
10. Tang W, Hemm I, Bertram B: Recent development of antitumor agents from Chinese herbal medicines; Part I. Low molecular compounds. Planta Med 2003, 69:97-108.
11. Kinghorn AD, Su BN, Jang DS, Chang LC, Lee D, Gu JQ, Carcache-Blanco EJ, Pawlus AD, Lee SK, Park EJ, Luendent M, Gills A, Bhat K, Park HS, Mata-Greenwoode E, Song LL, Jang M, Pezzuto JM: Natural Inhibitors of carcinogenesis. Planta Med 2004, 70:691-705.
12. Akihisa T, Yasukawa K, Oinuma H, Kasahara Y, Yamanouchi S, Takido M, Kumasi K, Tamura T: Triterpene alcohols from the flowers of compositae and their anti-inflammatory effects. Phytochemistry 1996, 43:1255-1260.
13. Della Logia R, Tubaro A, Sosa A, Becker H, Saar S, Isaac O: The role of triterpenoids in the topical anti-inflammatory activity of Calendula officinalis flowers. Planta Med 1994, 60:516-520.
14. Kalvatchev Z, Walder R, Garzaro D: Anti-HIV activity of extracts from Calendula officinalis flowers. Biomed Pharmacother 1997, 51:176-180.
15. Perez-Carreon JI, Crux-Jimenez G, Licea-Vega JA, Arce-Popoca E, Fattel-Fazenda S, Villa-Trevino S: Genotoxic and anti-genotoxic properties of Calendula officinalis extracts in rat liver cell cultures treated with diethylnitrosamine. Toxicol in Vitro 2002, 16:253-258.
16. Pommier P, Gomez F, Sunyach MP, D'Hombres A, Carrie C, Montbarbon X: Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol 2004, 22:1447-1453.
17. Boucaud-Maitre Y, Algernon O, Raynaud J: Cytotoxic and antitumoral activity of Calendula officinalis extracts. Pharmazie 1988, 43:220-221.
18. Yoshikawa M, Murakami T, Kishi A, Kageura T, Matsuda H: Medicinal flowers III. Marigold. (1): hypoglycemic, gastric emptying inhibitory, and gastroprotective principles and new oleanane-type triterpene oligoglycosides, calendasaponins A, B, C, and D, from Egyptian Calendula officinalis. Chem Pharm Bull 2001, 49:863-870.
19. Neukirch H, D'Ambrosio M, Dall-Via J, Guerriero A: Simultaneous quantitative determination of eight triterpenoid monoesters from flowers of 10 varieties of Calendula, officinalis L. and characterisation of a new triterpenoid monoester. Phytochem Anal 2004, 15:30-35.
20. Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J: Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 1996, 24:406-415.
21. Liebmann JE, Cook JA, Lipschultz C, Teague D, Fisher J, Mitchell JB: Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. Br J Cancer 1993, 68:1104-1109.
22. Singh RP, Dhanalakshmi S, Agarwal R: Phytochemicals as cell cycle modulators: a less toxic approach in halting human cancers. Cell Cycle 2002, 1:156-161.
23. Lowe SW, Lin AW: Apoptosis in cancer. Carcinogenesis 2000, 21:485-495.
24. Jo EH, Kim SH, Ra JC, Kim SR, Cho SD, Jung JW, Yang SR, Park JS, Hwang JW, Aruoma OI, Kim TY, Lee YS, Yang KS: Chemopreventive properties of the ethanol extract of Chinese licorice (Glycyrrhiza uralensis) root: induction of apoptosis and G1 cell cycle arrest in MCF-7 human breast cancer cells. Cancer Lett 2005, 230:239-247.
25. Kundu T, Dey S, Roy M, Siddiqui M, Bhattachrya RK: Induction of apoptosis in human leukaemia cells by black tea and its polyphenol theaflavin. Cancer Lett 2005, 230:111-121.
26. Garcia-Lora A, Pedrinaci S, Garrido F: Protein-bound polysaccharide K and interleukin-2 regulate different nuclear transcription factors in the NKL human natural killer cell line. Cancer Immunol Immunother 2001, 50:191-198.
27. Kudo S, Tanaka J, Kashida H, Tamegai Y, Endo S, Yamano HO: Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker. Oncol Rep 2002, 9:635-638.
28. Ohwada S, Ikeya T, Yokomori T, Kusaba T, Roppongi T, Takahashi T, Nakamura S, Kakinuma S, Iwazaki S, Ishikawa H, Kawate S, Nakajima T, Morishita Y: Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer. a randomised controlled study. Br J Cancer 2004, 90:1003-1010.
29. Kariya Y, Inoue N, Kihara T, Fujii M: Activation of human natural killer cells by the protein bound polysaccharide PSK independently of interferon and interleukin 2. Immunol Lett 1992, 31:241-245.
30. Algarra I, Collado A, Garcia-Lora A, Garrido F: Differential effect of protein-bound polysaccharide (PSK) on survival of experimental murine tumors. J Exp Clin Cancer Res 1999, 18:39-46.
31. Smyth MJ, Crowe NY, Hayakawa Y, Takeda K, Yagita H, Godfrey DI: NKT cells - conductors of tumor immunity? Curr Opin Immunol 2002, 14:165-171.
32. Crowe NY, Smyth MJ, Godfrey DI: A critical role for natural killer T cells in Immunosurveillance of methylcholanthrene-induced sarcomas. J Exp Med 2002, 196:119-127.